Early Detection of T1D: Why Psychosocial Care and Language Matter
Maartje de Wit, Laura Yvonne Klinker, Belinda Moore, Anna Boggiss, Lucía Feito Allonca, Mariam Asaad, Keely Bebbington, Bryan Cleal, Sasja Huisman, Per Winterdijk, Henk Jan Aanstoot, Christine Fransman, Elizabeth Holmes-Truscott, Norbert Hermanns, Giesje Nefs
Psychosocial aspects of early detection in type 1 diabetes: Language matters, decision making and support needs. Diabet Med. 2026 Feb 5:e70246. Diabet Med. 2026 Apr 1:e70308.
Advances in early detection of type 1 diabetes (T1D)—through autoantibody screening and longitudinal monitoring—are rapidly changing the landscape of diabetes care. Identifying individuals in early stages of T1D can reduce the risk of diabetic ketoacidosis at diagnosis and enable earlier intervention. However, early detection also introduces a new reality: individuals and families must live with uncertainty about if and when clinical diabetes will develop. This raises important psychosocial and ethical questions that are not yet fully addressed in current care pathways.
This narrative review, co-authored by Diabeter NL / DCAauthors, examines the psychosocial implications of early T1D detection across the full pathway—from decision-making about screening to long-term monitoring. The paper integrates evidence from screening research, behavioural science, and clinical experience to identify key challenges and provide recommendations for person-centred, psychologically informed care. Central themes include:
- The psychological impact of risk knowledge
- The role of communication and language
- Decision-making under uncertainty
- The need for structured psychosocial support
Key POINTS:
- Emotional impact is real, but varies: Screening and detection of autoantibodies can lead to anxiety, distress, or uncertainty, particularly in parents. These reactions are often temporary but may persist in vulnerable groups.
- Uncertainty is a core challenge: Individuals may know they are at increased risk without knowing if or when T1D will develop. This long-term uncertainty shapes coping, decision-making, and engagement with care.
- Language strongly influences experience: Terms such as “risk” or “testing” can unintentionally create anxiety or misunderstanding. More neutral, person-centred language improves understanding and supports autonomy.
- Decision-making is value-driven: Choices about screening are not purely medical—they are influenced by beliefs, prior experiences, cultural context, and tolerance for uncertainty. Importantly, not participating should be presented as a valid option.
- Engagement in follow-up is not guaranteed: Long-term monitoring requires sustained motivation. Barriers include emotional burden, practical constraints, and misunderstanding of the purpose of monitoring.
This review highlights that early detection pathways must integrate psychosocial care from the start. For clinical practice, this means:
- Embedding psychological support and monitoring alongside medical follow-up
- Using clear, neutral, and non-stigmatising language
- Supporting shared decision-making, aligned with individual values
- Tailoring communication to age, literacy, and cultural context
Importantly, the findings extend beyond early T1D detection. They reflect a broader shift towards person-centred and equitable care, where outcomes depend not only on medical innovation, but also on how care is communicated, understood, and experienced. Successfully implementing early T1D detection pathways requires more than screening—it requires thoughtful communication, personalised support, and integration of psychosocial care. As early detection becomes more widespread, addressing these human factors will be essential to ensure that innovation translates into meaningful benefit for all.
Concluding, the authors state
"Integrating psychological monitoring and care is a critical component of the early T1D detection pathway." -
Please click here for the Pubmed link.